Clustering of KOR PET images separates people with AUD into distinct responses to naltrexone
Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry , 86 (11), 864-871, 2019 ). The purpose of the current study...
Saved in:
Published in | Brain imaging and behavior Vol. 17; no. 3; pp. 367 - 371 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.06.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al.
Biological Psychiatry
,
86
(11), 864-871,
2019
). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V
T
) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al.
Biological Psychiatry
,
62
(6), 694-697,
2007
) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone. |
---|---|
AbstractList | Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, VT) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone. Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V T ) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone. Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry , 86 (11), 864-871, 2019 ). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V T ) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry , 62 (6), 694-697, 2007 ) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone. Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V ) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects' responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone. Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, VT) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects' responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, VT) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects' responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone. |
Author | Hoye, Jocelyn Papademetris, Xenophon Krishnan-Sarin, Suchitra Morris, Evan D. Key, Jose Cosgrove, Kelly P. de Laat, Bart |
AuthorAffiliation | 3 Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA 1 Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, New Haven, CT, USA 2 Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA 4 Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA |
AuthorAffiliation_xml | – name: 1 Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, New Haven, CT, USA – name: 3 Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA – name: 4 Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA – name: 2 Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA |
Author_xml | – sequence: 1 givenname: Jocelyn surname: Hoye fullname: Hoye, Jocelyn email: Jocelyn.hoye@yale.edu organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine – sequence: 2 givenname: Jose surname: Key fullname: Key, Jose organization: Department of Biomedical Engineering, Yale School of Medicine – sequence: 3 givenname: Bart surname: de Laat fullname: de Laat, Bart organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine – sequence: 4 givenname: Kelly P. surname: Cosgrove fullname: Cosgrove, Kelly P. organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine, Department of Psychiatry, Yale School of Medicine – sequence: 5 givenname: Suchitra surname: Krishnan-Sarin fullname: Krishnan-Sarin, Suchitra organization: Department of Psychiatry, Yale School of Medicine – sequence: 6 givenname: Xenophon surname: Papademetris fullname: Papademetris, Xenophon organization: Department of Radiology and Biomedical Imaging, Yale School of Medicine, Department of Biomedical Engineering, Yale School of Medicine – sequence: 7 givenname: Evan D. surname: Morris fullname: Morris, Evan D. organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine, Department of Biomedical Engineering, Yale School of Medicine, Department of Psychiatry, Yale School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36695971$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUlvFDEQhS0URBb4AxyQJS5cGmx3ezuhaAiLiBSEkhuS5XFXTxz12I3tZvn3uJkwQA45efvq-VW9Y3QQYgCEnlLykhIiX2VKhWINYW1Tj1w14gE6orqljeSCH-z3XB6i45xvCOGd0vQROmyF0FxLeoS-rMY5F0g-bHAc8MeLz_jT2SX2W7uBjDNMNtlSdxPEaQT83ZdrfHr1BvtQIu59Lj64ghPkKYZcuXob7FgS_KheH6OHgx0zPLldT9DV27PL1fvm_OLdh9XpeeM6yUvTEaE1dxKkk1qxnmktujWzg2XOcTpoNhBHnOqJ0452fcvVGrRYO6tJNwBrT9Drne40r7fQOwgl2dFMqbaRfppovfn_Jfhrs4nfDKWK1jnIqvDiViHFrzPkYrY-OxhHGyDO2TC5DIzyTlT0-R30Js6pNl2pqkYkVVJV6tm_lvZe_ky-AmwHuBRzTjDsEUrMEq_ZxWtqvOZ3vGb5W90pcr7Y4uPSlh_vL213pXlawob01_Y9Vb8Aa5655g |
CitedBy_id | crossref_primary_10_1021_acs_jmedchem_2c01965 crossref_primary_10_1016_j_peptides_2024_171268 |
Cites_doi | 10.1016/j.neuroimage.2009.12.119 10.1007/s002130100919 10.2967/jnumed.112.118877 10.1111/acer.13406 10.1097/01.WCB.0000038000.34930.4E 10.1016/j.biopsych.2019.05.021 10.1016/j.biopsych.2006.11.018 10.1038/s41386-018-0199-1 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TK 7X7 7XB 88E 88G 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M2M M7P NAPCQ P5Z P62 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1007/s11682-023-00758-6 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1931-7565 |
EndPage | 371 |
ExternalDocumentID | PMC11815977 36695971 10_1007_s11682_023_00758_6 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR000142 – fundername: NIAAA NIH HHS grantid: R01 AA021818 – fundername: NIAAA NIH HHS grantid: P50 AA012870 |
GroupedDBID | --- -55 -5G -BR -EM -Y2 -~C .86 .VR 04C 06D 0R~ 0VY 1N0 203 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5VS 67Z 6J9 6NX 7RV 7X7 875 88E 8FE 8FG 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIVO ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ AXYYD AZQEC B-. BA0 BBNVY BDATZ BENPR BGLVJ BGNMA BHPHI BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIHBH EIOEI EJD EMOBN ESBYG EX3 F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HLICF HMCUK HMJXF HQYDN HRMNR HZ~ IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV LK8 LLZTM M1P M2M M4Y M7P MA- NAPCQ NPVJJ NQJWS NU0 O9- O93 O9J OAM P62 P9L PF0 PQQKQ PROAC PSQYO PSYQQ PT4 QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S3B SAP SBS SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 WOW YLTOR Z45 Z82 Z83 ZMTXR ZOVNA ~A9 ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c475t-406995c7e7c7982d29964b2afa2cc51f92f0c0c8d0c9c14d358be96bca904fe23 |
IEDL.DBID | 7X7 |
ISSN | 1931-7557 1931-7565 |
IngestDate | Thu Aug 21 18:29:00 EDT 2025 Thu Jul 10 17:33:21 EDT 2025 Fri Jul 25 10:39:50 EDT 2025 Thu Apr 03 07:05:13 EDT 2025 Thu Apr 24 22:58:47 EDT 2025 Tue Jul 01 04:04:35 EDT 2025 Fri Feb 21 02:44:43 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Spectral clustering Alcohol use disorder Positron emission tomography Small sample size Machine learning Kappa opioid receptor |
Language | English |
License | 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c475t-406995c7e7c7982d29964b2afa2cc51f92f0c0c8d0c9c14d358be96bca904fe23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 JH wrote code, analyzed data, prepared figure 1, and wrote the original draft of the manuscript. JK wrote code and analyzed data. BDL curated data, provided scientific interpretation, and edited the manuscript. KPC provided scientific interpretation and edited the manuscript. SK-S designed the ADP procedures, provided scientific interpretation, and edited the manuscript. XP designed the clustering procedures, provided clustering code, provided scientific interpretation, and edited the manuscript. EDM designed the study, designed the PET procedures, provided scientific interpretation, and edited the manuscript. Author’s Contributions |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11815977 |
PMID | 36695971 |
PQID | 2815071878 |
PQPubID | 1486349 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11815977 proquest_miscellaneous_2769591546 proquest_journals_2815071878 pubmed_primary_36695971 crossref_primary_10_1007_s11682_023_00758_6 crossref_citationtrail_10_1007_s11682_023_00758_6 springer_journals_10_1007_s11682_023_00758_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-06-01 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Indianapolis |
PublicationTitle | Brain imaging and behavior |
PublicationTitleAbbrev | Brain Imaging and Behavior |
PublicationTitleAlternate | Brain Imaging Behav |
PublicationYear | 2023 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Krishnan-Sarin, Krystal, Shi, Pittman, O’Malley (CR5) 2007; 62 Kim, Zheng, Nabulsi, Labaree, Ropchan, Najafzadeh, Carson, Huang, Morris (CR4) 2013; 54 de Laat, Goldberg, Shi, Tetrault, Nabulsi, Zheng, Najafzadeh, Gao, Kapinos, Ropchan, O'Malley, Huang, Morris, Krishnan-Sarin (CR2) 2019; 86 Ichise, Toyama, Innis, Carson (CR3) 2002; 22 O'Malley, Krishnan-Sarin, Farren, Sinha, Kreek (CR6) 2002; 160 CR8 Shen, Papademetris, Constable (CR7) 2010; 50 Anderson, Becker (CR1) 2017; 41 Vijay, Cavallo, Goldberg, de Laat, Nabulsi, Huang, Krishnan-Sarin, Morris (CR9) 2018; 43 SJ Kim (758_CR4) 2013; 54 B de Laat (758_CR2) 2019; 86 S Krishnan-Sarin (758_CR5) 2007; 62 M Ichise (758_CR3) 2002; 22 758_CR8 A Vijay (758_CR9) 2018; 43 RI Anderson (758_CR1) 2017; 41 SS O'Malley (758_CR6) 2002; 160 X Shen (758_CR7) 2010; 50 |
References_xml | – volume: 50 start-page: 1027 issue: 3 year: 2010 end-page: 1035 ident: CR7 article-title: Graph-theory based parcellation of functional subunits in the brain from resting-state fMRI data publication-title: Neuroimage. doi: 10.1016/j.neuroimage.2009.12.119 – volume: 160 start-page: 19 issue: 1 year: 2002 end-page: 29 ident: CR6 article-title: Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis publication-title: Psychopharmacology. doi: 10.1007/s002130100919 – volume: 54 start-page: 1668 issue: 9 year: 2013 end-page: 1674 ident: CR4 article-title: Determination of the in vivo selectivity of a new kappa-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey publication-title: Journal of Nuclear Medicine doi: 10.2967/jnumed.112.118877 – ident: CR8 – volume: 41 start-page: 1402 issue: 8 year: 2017 end-page: 1418 ident: CR1 article-title: Role of the dynorphin/kappa opioid receptor system in the motivational effects of ethanol publication-title: Alcoholism: Clinical and Experimental Research. doi: 10.1111/acer.13406 – volume: 22 start-page: 1271 issue: 10 year: 2002 end-page: 1281 ident: CR3 article-title: Strategies to improve Neuroreceptor parameter estimation by linear regression analysis publication-title: Journal of Cerebral Blood Flow & Metabolism. doi: 10.1097/01.WCB.0000038000.34930.4E – volume: 86 start-page: 864 issue: 11 year: 2019 end-page: 871 ident: CR2 article-title: The kappa opioid receptor is associated with naltrexone-induced reduction of drinking and craving publication-title: Biological Psychiatry doi: 10.1016/j.biopsych.2019.05.021 – volume: 62 start-page: 694 issue: 6 year: 2007 end-page: 697 ident: CR5 article-title: Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking publication-title: Biological Psychiatry doi: 10.1016/j.biopsych.2006.11.018 – volume: 43 start-page: 2539 issue: 13 year: 2018 ident: CR9 article-title: PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age publication-title: Neuropsychopharmacology. doi: 10.1038/s41386-018-0199-1 – volume: 22 start-page: 1271 issue: 10 year: 2002 ident: 758_CR3 publication-title: Journal of Cerebral Blood Flow & Metabolism. doi: 10.1097/01.WCB.0000038000.34930.4E – volume: 62 start-page: 694 issue: 6 year: 2007 ident: 758_CR5 publication-title: Biological Psychiatry doi: 10.1016/j.biopsych.2006.11.018 – volume: 160 start-page: 19 issue: 1 year: 2002 ident: 758_CR6 publication-title: Psychopharmacology. doi: 10.1007/s002130100919 – volume: 54 start-page: 1668 issue: 9 year: 2013 ident: 758_CR4 publication-title: Journal of Nuclear Medicine doi: 10.2967/jnumed.112.118877 – volume: 43 start-page: 2539 issue: 13 year: 2018 ident: 758_CR9 publication-title: Neuropsychopharmacology. doi: 10.1038/s41386-018-0199-1 – ident: 758_CR8 – volume: 86 start-page: 864 issue: 11 year: 2019 ident: 758_CR2 publication-title: Biological Psychiatry doi: 10.1016/j.biopsych.2019.05.021 – volume: 50 start-page: 1027 issue: 3 year: 2010 ident: 758_CR7 publication-title: Neuroimage. doi: 10.1016/j.neuroimage.2009.12.119 – volume: 41 start-page: 1402 issue: 8 year: 2017 ident: 758_CR1 publication-title: Alcoholism: Clinical and Experimental Research. doi: 10.1111/acer.13406 |
SSID | ssj0054891 |
Score | 2.3076982 |
Snippet | Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 367 |
SubjectTerms | Alcohol Drinking Alcohol use Alcoholism - diagnostic imaging Alcoholism - drug therapy Biomedical and Life Sciences Biomedicine Brief Report Clustering Drinking Drinking behavior Humans Image acquisition Magnetic Resonance Imaging Naltrexone Naltrexone - therapeutic use Neostriatum Neuropsychology Neuroradiology Neurosciences Opioid receptors (type kappa) Positron emission Positron-Emission Tomography - methods Psychiatry Receptors, Opioid, kappa Reduction Robustness Sarin Training Variance analysis |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aFEovJenTSVpU6K0VWFo9j0uaEFr6oGQhh4KxxzJdSLxl1wv9-RnJ9i7btIHejDV6eGakGWs0nwDekk2UJljk6BVy5WXJPdl93hhaCn3jha4T2ucXcz5THy_15ZAUthpPu48hybRSb5PdhCFvkGwMj3bOcXMfHuj4705aPJPTcf0lFzzdk0eeieBWazukyvy9jV1zdMvHvH1U8o94aTJDZ_vwePAf2bQX-AHcC-0TePh5iJA_hR8nV-uIfUCV2aJhn75-Z99OL9j8mtaNFVuFBPVNT_3JcRa3Ydl09oHN227B6jjhW-zYsj85S3T0lvrrluH3og3PYHZ2enFyzocbFDgqqzse01q9RkvCsN7JmmyPUZUsm1IiatF42eSYo6tz9ChUPdGuCt5UWPpcNUFOnsNeS82_BGYx906gi2FQZXPjrCNGYxnCRGClQwZiZGSBA7x4vOXiqtgCI0fmF8T8IjG_MBm829T51YNr3El9PMqnGCbaqpAuebQ0mgzebIppisS4R9mGxZporPGatE5REy96cW66m5hYZkUGbkfQG4IIv71b0s5_JhjumLIb0fsyeD_qxHZc__6Mw_8jP4JHMulr3Pg5hr1uuQ6vyA_qqtdJ7W8AN4H9DQ priority: 102 providerName: Springer Nature |
Title | Clustering of KOR PET images separates people with AUD into distinct responses to naltrexone |
URI | https://link.springer.com/article/10.1007/s11682-023-00758-6 https://www.ncbi.nlm.nih.gov/pubmed/36695971 https://www.proquest.com/docview/2815071878 https://www.proquest.com/docview/2769591546 https://pubmed.ncbi.nlm.nih.gov/PMC11815977 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0BfFF_DZaywq-6WKyl_16krPetVispfTgBCEkkw0e1KTe5cA_35lNLsdZ7EsSdjcfOzO7M9mZ_Q1jb1EnSu0NCHApiNTJXDjU-6LSOBW6yiWqDGifZ_pkln6Zq3m_4Lbqwyo3c2KYqMsGaI38g7TBdLHGfrz-LShrFHlX-xQad9k-QZdRSJeZDz9caIyHjHlooyTCKGX6TTPd1rlEo22JGkuQ1rRC7yqmG9bmzaDJfzynQSFNH7IHvSXJxx3rH7E7vn7M7n3tfeVP2I-jqzWhIODNvKn46bcLfj655ItfOIOs-MoH0G-86mLIOS3I8vHsM1_UbcNLGvo1tHzZxdBiOyzF97VL_6ep_VM2m04uj05En0tBQGpUK2iDq1NgkC3GWVmiFtJpIfMqlwAqqZysYojBljE4SNJypGzhnS4gd3FaeTl6xvZqfPwLxg3EziZgySGamlgjS5DQkHs_SqBQPmLJhpAZ9EDjlO_iKttCJBPxMyR-Foif6Yi9G-657mA2bm19sOFP1g-5VbYVkIi9GapxsJAHJK99s8Y2RjuF8pfiI5537BxeN9JUZ5KI2R1GDw0IiHu3pl78DIDctHmXcPwi9n4jE9vv-n83Xt7ejVfsvgzySUs-B2yvXa79a7SA2uIwiDke7fT4kO2Pj7-fTvD8aXJ2foGlMzn-C7LWBTQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxJuUAkaCE1gkTvw6IFS1XbZsWxDalXpAShPHESuVpN3NCvhT_EZmnGRXS0VvvUXxI_Z4PDPxeL4h5BXoRC6dssyaxLLE8IwZ0PuslCAKTWkiUXi0z2M5nCSfTsTJBvnTx8LgtcpeJnpBXdQWz8jfce1NF630h_MLhlmj0Lvap9Bo2WLkfv-EX7b5-4M9WN_XnA_2x7tD1mUVYDZRomEY6mmEVTBAZTQvQB7LJOdZmXFrRVQaXoY2tLoIrbFRUsRC587I3GYmTEqHQAcg8m8kcWxwR-nBx17yg_HvM_SBTRQxJYTqgnTaUL1Igi0LGpKhltZMrivCS9bt5Uua_3hqvQIc3CV3OsuV7rSsdo9suOo-uXnU-eYfkG-7ZwtEXYDGtC7p6PNX-mV_TKc_QGLN6dx5kHF4au-sUzwApjuTPTqtmpoWKGoq29BZe2cX6sFb-F4zc7_qyj0kk2uh8iOyWUH3TwhVNjQ6shodsIkKJbAAENpmzsWRzYULSNQTMrUdsDnm1zhLV5DMSPwUiJ964qcyIG-Wbc5bWI8ra2_365N2W3yerhgyIC-XxbA50eOSVa5eQB0ljQB-T6CLx-1yLj8XSyxTUUD02kIvKyDw93pJNf3uAcAxWBhxAwPytueJ1bj-P42tq6fxgtwajo8O08OD49FTcpt7XsXjpm2y2cwW7hlYX03-3LM8JafXvcf-AoIWPWs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIU28IL4JDDASPIG12I2_HhCa1lUbhTGhVeoDUkgcR1QayWhTAf8afx13TtKqTOxtb1XtfJ3vy7673xHyEmyiUF475mziWGJFxizYfVYqUIW2tFwWAe3zRB1NkvdTOd0if_paGEyr7HViUNRF7fCMfE-Y4LoYbfbKLi3idDh6d_GDYQcpjLT27TRaFhn73z9h-7Z4ezyEtX4lxOjw7OCIdR0GmEu0bBiWfVrpNLystkYUoJtVkouszIRzkpdWlLGLnSliZx1PioE0ubcqd5mNk9Ij6AGo_xt6IDnKmJ6uNnuwEQjd-sA_4kxLqbuCnbZsjyvwa8FaMrTYhqlNo3jJ072csPlP1DYYw9FtcqvzYul-y3Z3yJav7pKdj12c_h75cnC-RAQGuJjWJR1_-kxPD8_o7DtorwVd-AA4Dr_a_HWKh8F0fzKks6qpaYFqp3INnbf5uzAP_oXnNXP_q678fTK5Fio_INsV3P4RodrF1nBnMBib6FgBOwChXeb9gLtc-ojwnpCp60DOsdfGebqGZ0bip0D8NBA_VRF5vbrmooX4uHL2br8-aSfui3TNnBF5sRoGQcXoS1b5eglztLISeD-BWzxsl3P1uIHCMc0jYjYWejUBQcA3R6rZtwAGjoXDiCEYkTc9T6zf6_-f8fjqz3hOdkC60g_HJ-Mn5KYIrIonT7tku5kv_VNwxJr8WeB4Sr5et4j9BUrBQZg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clustering+of+KOR+PET+images+separates+people+with+AUD+into+distinct+responses+to+naltrexone&rft.jtitle=Brain+imaging+and+behavior&rft.au=Hoye%2C+Jocelyn&rft.au=Key%2C+Jose&rft.au=de+Laat%2C+Bart&rft.au=Cosgrove%2C+Kelly+P.&rft.date=2023-06-01&rft.issn=1931-7557&rft.eissn=1931-7565&rft.volume=17&rft.issue=3&rft.spage=367&rft.epage=371&rft_id=info:doi/10.1007%2Fs11682-023-00758-6&rft_id=info%3Apmid%2F36695971&rft.externalDocID=PMC11815977 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-7557&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-7557&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-7557&client=summon |